Effectiveness of rivastigmine in Alzheimer's disease - Participation in trials should be based on clinical uncertainty, not enforcement

被引：7

作者：

Bullock, R ^{[1
]}

Passmore, P

Wilkinson, D

Howard, R

Jones, R

机构：

[1] Victoria Hosp, Kinghill Res Ctr, Swindon SN1 4JU, Wilts, England

[2] Queens Univ Belfast, Belfast BT9 7BL, Antrim, North Ireland

[3] Moorgreen Hosp, Thornhill Res Ctr, Southampton SO30 3JB, Hants, England

[4] Inst Psychiat, London SE5 8AF, England

[5] St Martins Hosp, Res Inst Care Elderly, Bath BA2 5RP, Avon, England

来源：

BRITISH MEDICAL JOURNAL | 2000年 / 320卷 / 7233期

关键词：

D O I：

10.1136/bmj.320.7233.511

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：511 / 512

页数：2

共 5 条

[1] Effectiveness of rivastigmine in Alzheimer's disease - Improvements in functional ability remain unestablished [J].

Bentham, P ;

Gray, R ;

Sellwood, E ;

Raftery, J .

BRITISH MEDICAL JOURNAL, 1999, 319 (7210) :640-641

[2] Assessment of activities of daily living in dementia: Development of the Bristol activities of daily living scale [J].

Bucks, RS ;

Ashworth, DL ;

Wilcock, GK ;

Siegfried, K .

AGE AND AGEING, 1996, 25 (02) :113-120

[3]

Collins R, 1992, INTRO NEW TREATMENTS, P49

[4] Personal paper - New drug treatment for Alzheimer's disease: lessons for healthcare policy [J].

Melzer, D .

BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7133) :762-764

[5] ASSESSING PATIENT DEPENDENCE IN ALZHEIMERS-DISEASE [J].

STERN, Y ;

ALBERT, SM ;

SANO, M ;

RICHARDS, M ;

MILLER, L ;

FOLSTEIN, M ;

ALBERT, M ;

BYLSMA, FW ;

LAFLECHE, G .

JOURNALS OF GERONTOLOGY, 1994, 49 (05) :M216-M222

← 1 →